A glioma cell line derived from these tumors (named C266) was used to investigate its dependency on the EBP protein and susceptibility to clemastine, benztropine, and a small-molecule drug (CW3388) known to inhibit mouse EBP [56]. This evidence concerns the gene EBP and central nervous system cancer.